Next Article in Journal
Novel 6- and 7-Substituted Coumarins with Inhibitory Action against Lipoxygenase and Tumor-Associated Carbonic Anhydrase IX
Next Article in Special Issue
Rapid Screening and Identification of Daidzein Metabolites in Rats Based on UHPLC-LTQ-Orbitrap Mass Spectrometry Coupled with Data-Mining Technologies
Previous Article in Journal
Current NMR Techniques for Structure-Based Drug Discovery
Previous Article in Special Issue
Effects of Agitation, Aeration and Temperature on Production of a Novel Glycoprotein GP-1 by Streptomyces kanasenisi ZX01 and Scale-Up Based on Volumetric Oxygen Transfer Coefficient
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chemical Composition and Evaluation of the Biological Properties of the Essential Oil of the Dietary Phytochemical Lippia citriodora

by
Eleni Fitsiou
1,
Gregoria Mitropoulou
1,
Katerina Spyridopoulou
1,
Manolis Vamvakias
2,
Haido Bardouki
2,
Alex Galanis
1,
Katerina Chlichlia
1,
Yiannis Kourkoutas
1,
Mihalis Ι. Panayiotidis
3,* and
Aglaia Pappa
1,*
1
Department of Molecular Biology and Genetics, Democritus University of Thrace, University Campus, Dragana, 68100 Alexandroupolis, Greece
2
VIORYL S.A., Chemical & Agricultural Industry, Research S.A., 19014 Afidnes, Greece
3
Department of Applied Sciences, Northumbria University, Newcastle Upon Tyne NE1 8ST, UK
*
Authors to whom correspondence should be addressed.
Submission received: 8 November 2017 / Revised: 3 January 2018 / Accepted: 7 January 2018 / Published: 12 January 2018

Abstract

:
The aim of the study was to characterize the chemical composition and biological properties of the essential oil from the plant Lippia citriodora grown in Greece. The essential oil volatiles were analyzed by gas chromatography–mass spectrometry GC-MS indicating citral as the major component. Τhe antimicrobial properties were assayed using the disk diffusion method and the minimum inhibitory and non-inhibitory concentration values were determined. Listeria monocytogenes, Staphylococcus epidermidis, Staphylococcus aureus, Saccharomyces cerevisiae, and Aspergillus niger were sensitive to Lippia citriodora oil, but not Escherichia coli, Salmonella Enteritidis, Salmonella typhimurium, and Pseudomonas fragi. Adversely, all microbes tested were sensitive to citral. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) assays were used to assess direct antioxidant activity, which proved to be weak for both agents, while comet assay was utilized to study the cytoprotective effects against H2O2-induced oxidative damage in Jurkat cells. Interestingly, the oil showed a more profound cytoprotective effect compared to citral. The antiproliferative activity was evaluated in a panel of cancer cell lines using the sulforhodamine B (SRB) and 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-S-(phenylamino) carbonyl-2-tetrazolium hydroxide (XTT) assays and both agents demonstrated potent antiproliferative activity with citral being more cytotoxic than the oil. Taken together, the essential oil of Lippia citriodora and its major component, citral, exert diverse biological properties worthy of further investigation.

1. Introduction

Nowadays, public interest for natural products has increased; thus research has focused on exploring their activities as therapeutic agents for a broad range of pathological conditions including various types of cancer. Phytochemicals have been shown to reduce cancer cell viability and migration and interfere with intracellular pathways by altering the expression profiles of many genes [1,2,3]. Based on the promising biological properties that many compounds possess and their few side-effects, dietary natural products have attained a significant interest in being used as protective and therapeutic agents against cancer. In addition, there is also a growing trend in discovering new compounds of natural origin as food preservatives with many of them possessing such potential [4]. Thus, there is an ever-increasing trend in identifying novel natural compounds with biological significance for their exploitation both in the pharmaceutical and food industries.
Lippia citriodora, commonly known as lemon verbena, belongs to the Lippia genus, which contains around 200 species. It was originally cultivated in South and Central America and was brought to Europe in the 17th century [5]. There are published data on the activities of different extracts of the plant prepared by infusion or decoction [6,7,8]. Its leaves are mainly used for the preparation of infusions which have been utilized for the relief of gastrointestinal symptoms. Ιn addition, antispasmodic, diuretic, and sedative properties have also been described; however, the literature is sparse regarding the biological activities of the essential oil extracted from the plant.
Therefore, the aim of this study was to identify the composition of the essential oil of Lippia citriodora isolated from Greek plants and characterize its biological activities. We report here the (i) antimicrobial; (ii) antioxidant; (iii) cytoprotective (against H2O2-induced oxidative damage), and (iv) antiproliferative properties associated with the essential oil fraction derived from the leaves and stems of the plant. Finally, its major component, citral, was also evaluated for its biological properties in vitro and compared to the essential oil. To our knowledge, this is the first detailed study on distinct biological properties of the essential oil fraction of Lippia citriodora.

2. Results and Discussion

2.1. Chemical Composition

A total of 43 compounds, representing 87% of the total chromatographic area, were identified (Table 1). Neral (cis-citral) and geranial (trans-citral) reported as citral (which is the sum of the two isomers) accounted for 17.2% and 26.4%, respectively. Other major compounds identified were nerol (8.0%), geraniol (5.7%), spathulenol (3.3%), 1.8 cineol (3.2%) and limonene (2.2%). The results of the present study are in accordance with existing literature as geranial is reported as one of the main components of Citriodora species essential oil [9].

2.2. Antimicrobial Activitys

The antimicrobial activity of Lippia citriodora essential oil and its main constituent was evaluated against seven common food spoilage and pathogenic bacteria, as well as against S. cerevisiae and A. niger, which have been used previously as model systems in food spoilage.
Initially, the disk diffusion method was applied and subsequently the minimum inhibitory concentration (MIC) and non-inhibitory concentration (NIC) values were assessed using an established optical density method, which combines the absorbance measurements with the common dilution method. Non-linear regression analysis was used to fit the data using a previously-published model [10,11]. The data indicated that only S. epidermidis, S. aureus, and L. monocytogenes were sensitive to Lippia citriodora essential oil, although all bacteria were sensitive to citral (Table 2). Of note, large inhibition zones were observed in both S. cerevisiae uvaferm NEM (Table 2) and A. niger 19111 for both agents (inhibition zone of 20 ± 0.5 mm for 100 spores/plate initial inoculum) (the inhibition zones disappeared after one day οf incubation), which were similar to the positive control [12].
In accordance with the results of the disc diffusion method, MIC and NIC determination documented the effective growth inhibition of Lippia citriodora essential oil against S. epidermidis, S. aureus, and L. monocytogenes and citral against all bacteria tested (Table 3), although MIC and NIC values were significantly (p < 0.05) higher compared to ciproxin, which was used as positive control [12]. Noticeably, the oil was more effective compared to citral, as significantly (p < 0.05) lower MIC and NIC values were recorded. Similar results reporting high antimicrobial activity of Lippia citriodora essential oil and extracts were previously reported [6,13,14]. However, they were only limited to disc or well diffusion assays and no MIC and NIC values were determined. The antimicrobial activity of the essential oil could be attributed to the action of its main constituent, although possible antagonistic effects should not be excluded [15,16]. Such effects must be further studied using model systems.

2.3. Antioxidant Activity

In the present study, the DPPH and ABTS assays were used for the evaluation of the antioxidant capacity of the oil and citral. More particularly, increasing concentrations of the essential oil (0.0046–46 mg/mL) and citral (0.0045–45 mg/mL) were incubated with DPPH and ABTS for 30 and 15 min, respectively. The IC50 values for the essential oil were 6.3 ± 0.25 mg/mL for the DPPH assay and 3.08 ± 0.3 mg/mL using the ABTS method. Citral did not show any significant antioxidant activity (maximum DPPH inhibition 3.9% and ABTS inhibition 22.45%; Table 4).
The radical scavenging activity of citral has been tested before using the DPPH and ABTS assays, showing significant activity (IC50 values ranging from 30 to 260 μg/mL), in disagreement with our results [17,18,19]. Compared to lemon verbena oil, its activity was weaker showing that the oil probably owes its radical scavenging activity to its other constituents, as this is the case for other oils as well [20]. Both assays showed the same trend, however, in the ABTS method, both agents demonstrated a more potent antioxidant potential. Regardless of the assays used, their activity was shown to be less when compared to the potent antioxidant, ascorbic acid (Table 4). Differences in the results from the two assays have been reported before, where extracts were found to be more effective as ABTS rather than DPPH scavengers [21,22]. These differences can be attributed to a variety of factors, such as stereoselectivity of the radicals, solubility of the extracts in the different systems, and underlying mechanism(s) of action of the reaction [23,24].

2.4. Genotoxic or Cytoprotective (Against H2O2-Induced Oxidative Damage) Activity

The genotoxic effects of the oil fraction or citral were investigated using the comet assay. We observed that the oil fraction demonstrated a genotoxic effect only at the highest concentration used (920 μg/mL) in Jurkat cells after 20 min of incubation, which was approximately one and a half times the levels of DNA damage of the control sample (Figure 1A). Conversely, citral exhibited a non-concentration dependent genotoxicity that reached the levels of the maximum oil-induced DNA damage at a very low concentration (44.8 μg/mL) (Figure 1B). In addition, it caused a 2.2-fold DNA damage compared to the control group at the highest concentration used (448 μg/mL), which was half the maximum concentration of the oil (920 μg/mL).
Moreover, we used two concentrations of both agents (essential oil, 92 and 640 μg/mL; citral, 4.48 and 44.8 μg/mL) to assess the protective effect of each agent against H2O2-induced oxidative damage. Overall, both agents exhibited similar levels of protection only at the highest concentration used, with the oil providing slightly more protection than citral (2.24-fold vs. 2.7-fold the DNA of control sample, respectively) (Figure 2A,B).
The oil from Lippia citriodora together with citral have been previously evaluated for their antigenotoxic effect against ultraviolet radiation-induced DNA damage using the SOS chromosome test, where they both showed antigenotoxicity [25]. Citral has shown diverse toxicity using different test systems. For instance, it not did exhibit direct pro-oxidant effect when testing oxygen uptake in erythrocytes exposed to tert-butyl hydroperoxide (t-BHP) [26], nor did it reduce the viability of rat small intestine epithelial cells after 24 h of incubation [17]. When using the Salmonella mutagenicity testing, Gomes-Carneiro et al., demonstrated that citral was toxic at concentrations higher than 600 μg/mL, whereas it did not demonstrate any such genotoxicity when utilizing the SOS chromotest [27,28]. Moreover, in a similar study, citral was shown to reduce the viability of human lymphocytes over 100 μg/mL using the MTT assay and cause statistically significant DNA damage at even lower concentrations (>25 μg/mL), in accordance with our results [29].

2.5. Antiproliferative Activity

Increasing concentrations of the essential oil fraction (0.64–920 μg/mL) or citral (0.63–900 μg/mL) were incubated with different human cancer cell lines (for 72 h) and SRB or XTT assays were employed to determine cell viability. Overall, it was observed that the oil fraction was most cytotoxic against the A375 (melanoma) cells (EC50 = 9.1 ± 0.6 μg/mL), an activity eight to ten times higher compared to the other cell lines tested. In addition, it showed similar viability levels against HepG2 (hepatocellular carcinoma), MCF-7 (breast adenocarcinoma) and Caco2 (colon adenocarcinoma) cells (EC50 = 74 ± 2.8 μg/mL, 89 ± 1.4 μg/mL and 71 ± 2.6 mg/mL, respectively), while it was slightly less cytotoxic against THP-1 (leukemic monocytes) cells (EC50 = 111 ± 3.6 μg/mL) (Figure 3 and Table 5). Finally, the oil fraction demonstrated modest cytotoxicity to the lines tested compared with etoposide, a known chemotherapeutic agent. To our knowledge, there are no published data on the cytotoxicity of the essential oil of Lippia citriodora against HepG2 and Caco2 cell lines. In a study in 2010, Escobar et al. showed the effect of Lippia citriodora oil (from Colombian plants) against Vero and THP-1 cells where the EC50 value for THP-1 was >100 μg/mL, in accordance with our results [30]. There is also one study describing the cytotoxic activity of Aloysia citriodora oils from different regions of Morocco against MCF-7 cells after a 48 h incubation, where the EC50 values ranged between 35 and 70 μg/mL, whereas there was no cytotoxicity observed against PBMCs [31]. In this case, the oils demonstrated higher activity compared to our oil, which may be attributed to the differences in their composition, as the Moroccan oils had β-spathulenol, trans-caryophyllene oxide and ar-curcumene as major components.
On the other hand, citral was significantly more potent against all cell lines tested, an observation which could owe to an antagonistic effect between the components of the essential oil. In general, MCF-7 cells were the most sensitive ones when subjected to citral (EC50 = 1.3 ± 0.19 μg/mL), followed by Caco2 and HepG2 cells (EC50 = 3.7 ± 0.21 μg/mL and 7 ± 0.35 μg/mL, respectively) (Figure 4 and Table 5). To this end, another study utilizing citral (obtained commercially) and also tested against MCF-7 cells showed an EC50 value of 22 μg/mL [32], an effect significantly smaller than that of our study, which may be attributed to the different cell viability assay used. In another study, citral has been tested against HepG2 cells after 24 and 48 h of incubation (EC50 = 30.129 and 14.67 μg/mL, respectively), in accordance with our results, where after 72 h the EC50 value was even lower, suggesting a time-dependent effect [19], while it has also been tested for its cytotoxicity against a range of human cancer cell lines including breast carcinoma, glioblastoma, malignant melanoma, and colon carcinoma after a 72 h incubation, exhibiting potent activity [18].

3. Materials and Methods

3.1. Plant Material

Plant material was purchased by Vioryl S.A. from a local area herbal market (Afidnes, Athens, Greece) and the species was confirmed by a professional botanist. Plants were small shrubs of almost 60 cm height. They were kept in pots until the first inflorescence appeared and leaves and stems were collected.

3.2. Chemicals and Reagents

Brain heart infusion (BHI) broth, malt extract agar, and Ringer’s solution were obtained from LABM (Heywood, UK). Ciproxin was obtained from Oxoid Ltd. (Basingstoke, UK) and amphotericin B from Mast Group Ltd. (Merseyside, UK). Dulbecco’s Modified Eagle’s Medium (DMEM), DMEM high glucose, RPMI media, and low melting agarose were purchased from Gibco® (Gaithersburg, MD, USA). Fetal bovine serum (FBS), trypsin, penicillin/streptomycin, trypan blue 0.5%, and phosphate-buffered saline (PBS) were purchased from Biosera (Boussens, France). Dimethyl sulfoxide (DMSO) and propidium iodide were purchased from Biotium (Hayward, CA, USA), while hydrogen peroxide, ABTS, potassium persulfate, ascorbic acid, sulforhodamine B (SRB), Trizma base, and etoposide were purchased from Sigma-Aldrich (St. Louis, MO, USA). Trichloroacetic acid (TCA) was obtained from MP Biomedicals (Santa Ana, CA, USA). Acetic acid and ethanol were purchased from Scharlau (Barcelona, Spain) and DPPH from Calbiochem® (Darmstadt, Germany).

3.3. Essential Oil Extraction and GC/MS Analysis

The essential oil was obtained by hydrodistillation at VIORYL S.A. facilities (Afidnes, Athens, Greece) directly after the harvesting period, taking into account the seasonality of the plant. All plants were harvested during May and June, and no further drying process was used. Chopped leaves and stems were collected by hand, followed by hydrodistillation with a Dean Stark apparatus. Plant material was covered with 6 L of distilled water, while the extraction process took place for 8 h at a temperature of 90–120 °C. Isolated essential oil was dried with Na2SO4 and sealed in vials for further use. Analysis was carried out with a GC-MS (GC: 6890A, Agilent Technologies, Santa Clara, CA, USA; MSD: 5973, Agilent Technologies, Santa Clara, CA, USA) using a Factor Four VF 1 ms column (25 m, 0.2 mm i.d., 0.33 μm film thickness, Agilent Technologies, Santa Clara, CA, USA). A volume of 0.1 μL of essential oil was directly injected and a 1:100 split ratio was applied. Oven temperature was set at 50 °C for 1 min, followed by a temperature gradient of 2.5 °C/min to 160 °C (for 20 min), then raised to 250 °C at 50 °C/min with a final isothermal period of 15 min. Helium was used as the carrier gas (flow rate 1 mL/min). Injector and transfer line temperatures were set to 200 °C and 250 °C, respectively. The mass spectrometer operated in the electron impact mode with the electron energy set to 70 eV. Identification of the compounds was carried out according to the standard method of Kováts Indices and comparison of volatiles mass spectra to Willey/NIST 0.5 and in-house created libraries (VIORYL S.A.).

3.4. Microbial Strains

Salmonella enterica subsp. enterica ser. Enteritidis FMCC Β56 PT4 (kindly provided by Prof. Nychas G.J.E., Agricultural University of Athens, Athens, Greece), Salmonella enterica subsp. enterica ser. typhimurium DSMZ 554, Listeria monocytogenes NCTC 10527 serotype 4b, Escherichia coli ATCC 25922, Staphylocοccus epidermidis FMCC B-202 C5M6 (kindly provided by Dr. Nisiotou A., Athens Wine Institute, ELGO-DIMITRA, Athens, Greece) and Staphylococcus aureus ATCC 25923 were grown in BHI at 37 °C for 24 h. Likewise, Pseudomonas fragi 211 (kindly provided by Prof. Nychas G.J.E., Agricultural University of Athens, Greece) was grown in BHI broth at 25 °C for 24 h. Saccharomyces cerevisiae uvaferm NEM (Lallemand, Montreal, QC, Canada) was grown in YPD broth (yeast extract, 10 g/L; glucose, 20 g/L; and peptone, 20 g/L) at 28 °C for three days. Aspergillus niger 19111 (kindly provided by Prof. Nychas G.J.E., Agricultural University of Athens) was grown on malt extract agar for seven days at 37 °C.

3.5. Antimicrobial Assays

The antimicrobial activity of the tested essential oil and determination of minimum inhibitory concentration (MIC) and non-inhibitory concentration (NIC) based on the Lambert-Pearson model (LPM) [10,11] were monitored using previously published methodologies [12,33]. In brief, the effect on the growth, measured by the optical density method, is manifested by a reduction in the area under the OD/time relative to a control well at any specified time (supplementary material). By calculating the area using the trapezoidal rule (Equation (1)), the relative amount of growth were obtained using the ratio of the test area to that of the control, termed the fractional area, fa. Data were fitted to the LPM using non-linear least squares regression analysis assuming equal variance.
f a = exp [ ( x P 1 ) P 2 ]
where fa is the fractional area, x is the inhibitor concentration (μg/mL), P1 is the concentration at maximum slope (of a logx vs. fa plot), and P2 is a slope parameter.
MIC was defined as the intercept of the concentration axis to the tangent at the maximum gradient of the fa/log concentration curve (Equation (2)):
M I C = P 1 exp ( 1 P 2 )
NIC was defined as the intercept of the tangent at the maximum gradient of the fa/log concentration curve to the fa = 1 contour (Equation (3)):
N I C = P 1 exp ( 1 e P 2 )

3.6. Antioxidant Activity

3.6.1. DPPH Assay

The radical scavenging activity of the essential oil and citral was estimated using the free radical DPPH, as previously described [12]. Increasing concentrations of the essential oil (0.0046–46 mg/mL) and citral (0.0045–45 mg/mL) were prepared using DMSO as the solvent. Absorbance was measured at 517 nm using an ELISA plate reader (EnSpire Multimode Plate Reader, Perkin Elmer, Waltham, MA, USA). All determinations were performed in triplicates. The % inhibition of the DPPH radical for each concentration was determined by making use of the following formula: % DPPH radical scavenging activity = [(ODcontrol − ODsample)/ODcontrol)] × 100.

3.6.2. ABTS Assay

The ABTS de-coloration assay was performed as previously described [12,34]. The % inhibition of the ABTS radical for each concentration is expressed in two ways; First, by making use of the following formula: % ABTS radical scavenging activity = [(ODcontrol − ODsample)/ODcontrol)] × 100. Next, a standard curve based on the percentage of ABTS radical scavenging activity of known concentrations of ascorbic acid expressed in μM was prepared and the concentrations of the samples were calculated using linear regression analysis and the results were also expressed as micromoles ascorbic acid equivalent per gram of essential oil (μmolesEA/g), by making use of the following formula: C = (cxD)/Ci. C, concentration of antioxidant compounds in μmolesEΑ/g; c, concentration of sample read (in micromoles per liter); D, dilution factor; Ci, concentration of stock solution (in grams per liter).

3.7. Cell Lines and Cell Cultures

The human cancer cell lines Caco2 (colorectal adenocarcinoma), HepG2 (hepatocellular carcinoma), MCF-7 (breast adenocarcinoma), ΤΗP-1 (leukemic monocytes), Jurkat (acute T cell leukemia), and A375 (malignant melanoma) were obtained from the American type culture collection (Rockville, MD, USA). HepG2 and MCF-7 cells were grown and maintained in DMEM, A375 cells in DMEM high glucose (4500 mg/L), whereas the medium RMPI was used for the Caco2, Jurkat, and THP-1 cell lines. All media were supplemented with 10% FBS, penicillin (100 U/mL), and streptomycin (100 μg/mL) and were incubated at 37 °C in a humidified atmosphere of 95% O2 and 5% CO2. Stock cultures were passaged at 2- to 3-day intervals. Cells were seeded at a density of 5.0 × 103 cells per well in 96-well plates for the SRB assay. THP-1 cells were seeded at a density of 2.0 × 103 cells per well in round bottom 96-well plates for the XTT assay.

3.8. Single Cell Gel Electrophoresis Assay (Comet Assay)

The alkaline version of the single-cell gel electrophoresis assay was used to evaluate DNA damage of the essential oil and citral, as well as their protective effect from H2O2-induced oxidative damage. Briefly, Jurkat cells (2 × 104 cells/sample in PBS) were maintained on ice. Cells were treated with increasing concentrations of the essential oil or citral alone for 20 min or followed by treatment with H2O2 (6.66 μg/mL) for another 20 min at room temperature. Comet assay was performed as previously described [35]. The slides were processed for evaluation on a Zeiss Axio Scope.A1 fluorescence microscope (Oberkochen, Germany). The overall DNA damage was calculated in arbitrary units. Results were expressed as % DNA damage relative to control.

3.9. Cell Viability Assays

3.9.1. SRB Assay

The viability of the human cancer cells HepG2, Caco2, MCF-7, and A375 after treatment with the essential oil and its major component was determined using the SRB assay as previously described [12]. Cells were plated in 96-well plates and treated with increasing concentrations of the oil (0.64–920 μg/mL) and citral (0.63–900 μg/mL) (dissolved in DMSO, 1:1 v/v) for 72 h.

3.9.2. XTT Assay

The viability of THP-1 cells was determined by the XTT assay as previously described [12,36]. Cells were seeded in a 96-well-plate and following an overnight incubation they were treated with increasing concentrations of the oil (0.64–920 μg/mL) or citral (0.63–900 μg/mL) (dissolved in DMSO, 1:1 v/v) for 72 h. At the end of the incubation, the XTT solution was added, and plates were incubated further for 4 h before reading the absorbance at 450 nm by a microplate reader (EnSpire Multimode Plate Reader, Perkin Elmer, Waltham, MA, USA).

3.10. Data Analysis

All experiments were performed at least in triplicate. For MIC and NIC determination, each experiment was performed at least 4 times, and standard deviation was calculated by Fig.P software (Fig.P Software Incorporated, Hamilton, ON, Canada). Significance was established at p < 0.05 and the results were analyzed for statistical significance with analysis of variance (ANOVA). Duncan’s multiple range test was used to determine significant differences among results using Statistica v.10.0. The IC50 (inhibition concentration) and EC50 (efficient concentration) values were calculated as previously described [12]. For comet assay, statistical differences between groups were evaluated by ANOVA followed by Dunnett’s or Tukey’s test. A level of p < 0.05 was considered statistically significant. All statistical analyses were performed using GraphPad Prism 5 (GraphPad Software, San Diego, CA, USA).

4. Conclusions

Citral is the major component of the essential oil of Lippia citriodora (obtained from Greek plants) and exhibited significant antimicrobial activity against all microbes tested in contrast to the oil fraction which was inactive against the gram negative bacteria. Our results also suggest that both the oil fraction and citral exhibit potent antiproliferative activities in vitro. More specifically, citral was more cytotoxic against all cancer cell lines utilized in the scope of this study while the oil fraction exhibited lower genotoxicity. Although both the oil and citral proved weak direct antioxidants as assessed by biochemical in vitro assays, they, nevertheless, exhibited antioxidant capacity in a cellular system demonstrated as a significant reduction of the H2O2-induced oxidative damage. Many of these properties are reported here for the first time, thus setting the basis for further investigations regarding the active components of the oil and the molecular mechanisms(s) underlying their mode of action. This is of utmost importance as the demand in identifying natural products with well-described biological properties for potential neutraceutical and pharmaceutical applications is constantly increasing.

Supplementary Materials

Supplementary materials are available online.

Acknowledgments

We acknowledge support of this work by the project “OPENSCREEN-GR: An Open-Access Research Infrastructure of Target-Based Screening Technologies and Chemical Biology for Human and Animal Health, Agriculture and Environment” (MIS ‎5002691) which is implemented under the Action “Reinforcement of the Research and Innovation Infrastructure”, funded by the Operational Programme “Competitiveness, Entrepreneurship and Innovation” (NSRF ‎2014-2020) and co-financed by Greece and the European Union (European Regional 326 Development Fund). Start-up funds provided by the MDRT “Bioeconomy” at Northumbria University-Newcastle, UK to M.I.P. are kindly acknowledged. The authors thank C. Tassou for providing full access to microplate reader equipment, N. Chorianopoulos for his valuable technical support and scientific advice, and greatly acknowledge the assistance of Eleni Papavasilopoulou and Dimitris Georganakis from VIORYL S.A.

Author Contributions

H.B., M.I.P., A.G., K.C., Y.K. and A.P. conceived and designed the experiments; E.F., G.M., K.S., M.V. and H.B. performed the experiments; E.F., G.M. and K.S. analyzed the data; and E.F., Y.K. and A.P. wrote the paper.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. González-Vallinas, M.; González-Castejón, M.; Rodríguez-Casado, A.; Ramírez de Molina, A. Dietary phytochemicals in cancer prevention and therapy: A complementary approach with promising perspectives. Nutr. Rev. 2013, 71, 585–599. [Google Scholar] [CrossRef] [PubMed]
  2. Miller, P.E.; Snyder, D.C. Phytochemicals and cancer risk: A review of the epidemiological evidence. Nutr. Clin. Pract. 2012, 27, 599–612. [Google Scholar] [CrossRef] [PubMed]
  3. Stagos, D.; Amoutzias, G.D.; Matakos, A.; Spyrou, A.; Tsatsakis, A.M.; Kouretas, D. Chemoprevention of liver cancer by plant polyphenols. Food Chem. Toxicol. 2012, 50, 2155–2170. [Google Scholar] [CrossRef] [PubMed]
  4. Tongnuanchan, P.; Benjakul, S. Essential oils: Extraction, bioactivities, and their uses for food preservation. J. Food Sci. 2014, 79, R1231–R1249. [Google Scholar] [CrossRef] [PubMed]
  5. Quirantes-Piné, R.; Herranz-López, M.; Funes, L.; Borrás-Linares, I.; Micol, V.; Segura Carretero, A.; Fernández-Gutiérrez, A. Phenylpropanoids and their metabolites are the major compounds responsible for blood-cell protection against oxidative stress after administration of Lippia citriodora in rats. Phytomedicine 2013, 20, 1112–1118. [Google Scholar] [CrossRef] [PubMed]
  6. Mothana, R.A.; Abdo, S.A.; Hasson, S.; Althawab, F.M.; Alaghbari, S.A.; Lindequist, U. Antimicrobial, antioxidant and cytotoxic activities and phytochemical screening of some Yemeni medicinal plants. Evid. Based Complement. Altern. Med. 2010, 7, 323–330. [Google Scholar] [CrossRef] [PubMed]
  7. Portmann, E.; Nigro, M.M.; Reides, C.G.; Llesuy, S.; Ricco, R.A.; Wagner, M.L.; Gurni, A.A.; Carballo, M.A. Aqueous extracts of Lippia turbinata and Aloysia citriodora (Verbenaceae): Assessment of antioxidant capacity and DNA damage. Int. J. Toxicol. 2012, 31, 192–202. [Google Scholar] [CrossRef] [PubMed]
  8. Valentão, P.; Fernandes, E.; Carvalho, F.; Andrade, P.B.; Seabra, R.M.; de Lourdes Basto, M. Studies on the antioxidant activity of Lippia citriodora infusion: Scavenging effect on superoxide radical, hydroxyl radical and hypochlorous acid. Biol. Pharm. Bull. 2002, 25, 1324–1327. [Google Scholar] [CrossRef] [PubMed]
  9. Linde, J.; Combrinck, S.; Regnier, T.; Virijevic, S. Chemical composition and antifungal activity of the essential oils of Lippia rehmannii from South Africa. S. Afr. J. Bot. 2010, 76, 37–42. [Google Scholar] [CrossRef]
  10. Chorianopoulos, N.; Lambert, R.J.W.; Skandamis, P.N.; Evergetis, E.T.; Haroutounian, S.A.; Nychas, G.J.E. A newly developed assay to study the minimum inhibitory concentration of Satureja spinosa essential oil. J. Appl. Microbiol. 2006, 100, 778–786. [Google Scholar] [CrossRef] [PubMed]
  11. Lambert, R.J.W.; Lambert, R. A model for the efficacy of combined inhibitors. J. Appl. Microbiol. 2003, 95, 734–743. [Google Scholar] [CrossRef] [PubMed]
  12. Fitsiou, E.; Mitropoulou, G.; Spyridopoulou, K.; Tiptiri-Kourpeti, A.; Vamvakias, M.; Bardouki, H.; Panayiotidis, M.Ι.; Galanis, A.; Kourkoutas, Y.; Chlichlia, K.; et al. Phytochemical Profile and Evaluation of the Biological Activities of Essential Oils Derived from the Greek Aromatic Plant Species Ocimum basilicum, Mentha spicata, Pimpinella anisum and Fortunella margarita. Molecules 2016, 21, 1069. [Google Scholar] [CrossRef] [PubMed]
  13. Ali, H.F.; El-Beltagi, H.S.; Nasr, N.F. Evaluation of antioxidant and antimicrobial activity of Aloysia triphylla. Electron. J. Environ. Agric. Food Chem. 2011, 10, 3044–3053. [Google Scholar]
  14. Koohsari, H.; Ghaemi, E.A.; Poli, M.S.S.; Sadegh, A. Evaluation of antibacterial activity of Lemon verbena (Lippia citriodora) leaves. Ann. Biol. Res. 2013, 4, 52–55. [Google Scholar]
  15. Burt, S. Essential oils: Their antibacterial properties and potential applications in foods—A review. Int. J. Food Microbiol. 2004, 94, 223–253. [Google Scholar] [CrossRef] [PubMed]
  16. Nazzaro, F.; Fratianni, F.; De Martino, L.; Coppola, R.; De Feo, V. Effect of Essential Oils on Pathogenic Bacteria. Pharmaceuticals 2013, 6, 1451–1474. [Google Scholar] [CrossRef] [PubMed]
  17. Bouzenna, H.; Hfaiedh, N.; Giroux-Metges, M.A.; Elfeki, A.; Talarmin, H. Biological properties of citral and its potential protective effects against cytotoxicity caused by aspirin in the IEC-6 cells. Biomed. Pharmacother. 2017, 87, 653–660. [Google Scholar] [CrossRef] [PubMed]
  18. Maggi, F.; Fortuné Randriana, R.; Rasoanaivo, P.; Nicoletti, M.; Quassinti, L.; Bramucci, Μ.; Lupidi, G.; Petrelli, D.; Vitali, L.A.; Papa, F.; et al. Chemical composition and in vitro biological activities of the essential oil of Vepris macrophylla (BAKER) I. Verd. endemic to Madagascar. Chem. Biodivers. 2013, 10, 356–366. [Google Scholar] [CrossRef] [PubMed]
  19. Shi, C.; Zhao, X.; Liu, Z.; Meng, R.; Chen, X.; Guo, N. Antimicrobial, antioxidant, and antitumor activity of epsilon-poly-l-lysine and citral, alone or in combination. Food Nutr. Res. 2016, 60, 31891. [Google Scholar] [CrossRef] [PubMed]
  20. Dawidowicz, A.L.; Olszowy, M. Does antioxidant properties of the main component of essential oil reflect its antioxidant properties? The comparison of antioxidant properties of essential oils and their main components. Nat. Prod. Res. 2014, 28, 1952–1963. [Google Scholar] [CrossRef] [PubMed]
  21. Bendif, H.; Boudjeniba, M.; Miara, M.D.; Biqiku, L.; Bramucci, M.; Lupidi, G.; Quassinti, L.; Maggi, F. Essential oil of Thymus munbyanus subsp. coloratus from Algeria: Chemotypification and in vitro biological activities. Chem. Biodivers. 2016, 14. [Google Scholar] [CrossRef]
  22. Osuna-Ruiz, I.; López-Saiz, C.M.; Burgos-Hernández, A.; Velázquez, C.; Nieves-Soto, M.; Hurtado-Oliva, M.A. Antioxidant, antimutagenic and antiproliferative activities in selected seaweed species from Sinaloa, Mexico. Pharm. Biol. 2016, 54, 2196–2210. [Google Scholar] [CrossRef] [PubMed]
  23. Bayala, B.; Bassole, I.H.; Gnoula, C.; Nebie, R.; Yonli, A.; Morel, L.; Figueredo, G.; Nikiema, J.B.; Lobaccaro, J.M.; Simpore, J. Chemical composition, antioxidant, anti-inflammatory and antiproliferative activities of essential oils of plants from Burkina Faso. PLoS ONE 2014, 9, e92122. [Google Scholar] [CrossRef] [PubMed]
  24. Yu, L.; Haley, S.; Perret, J.; Harris, M.; Wilson, J.; Qian, M. Free radical scavenging propertiesof wheat extracts. J. Agric. Food Chem. 2002, 50, 1619–1624. [Google Scholar] [CrossRef] [PubMed]
  25. Quintero Ruiz, N.; Córdoba Campo, Y.; Stashenko, E.E.; Fuentes, J.L. Antigenotoxic Effect Against Ultraviolet Radiation-induced DNA Damage of the Essential Oils from Lippia Species. Photochem. Photobiol. 2017, 93, 1063–1072. [Google Scholar] [CrossRef] [PubMed]
  26. Sanches, L.J.; Marinello, P.C.; Panis, C.; Fagundes, T.R.; Morgado-Díaz, J.A.; de-Freitas Junior, J.C.; Cecchini, R.; Cecchini, A.L.; Luiz, R.C. Cytotoxicity of citral against melanoma cells: The involvement of oxidative stress generation and cell growth protein reduction. Tumour Biol. 2017, 39, 1010428317695914. [Google Scholar] [CrossRef] [PubMed]
  27. Gomes-Carneiro, M.R.; Felzenszwalb, I.; Paumgartten, F.J. Mutagenicity testing (+/−)camphor,1,8 cineole, citral, citronellal, (−)-menthol and terpineol with the Salmonella/microsome assay. Mutat. Res. 1998, 416, 129–136. [Google Scholar] [CrossRef]
  28. López, M.A.; Stashenko, E.E.; Fuentes, J.L. Chemical composition and antigenotoxic properties of Lippia alba essential oils. Genet. Mol. Biol. 2011, 34, 479–488. [Google Scholar] [CrossRef] [PubMed]
  29. Sinha, S.; Jothiramajayam, M.; Ghosh, M.; Mukherjee, A. Evaluation of toxicity of essential oils palmarosa, citronella, lemongrass and vetiver in human lymphocytes. Food Chem. Toxicol. 2014, 68, 71–77. [Google Scholar] [CrossRef] [PubMed]
  30. Escobar, P.; Milena Leal, S.; Herrera, L.V.; Martinez, J.R. Stashenko, E. Chemical composition and antiprotozoal activities of Colombian Lippia spp essential oils and their major components. Mem. Inst. Oswaldo Cruz 2010, 105, 184–190. [Google Scholar] [CrossRef] [PubMed]
  31. Oukerrou, M.A.; Tilaoui, M.; Mouse, H.A.; Leouifoudi, I.; Jaafari, A.; Zyad, A. Chemical Composition and Cytotoxic and Antibacterial Activities of the Essential Oil of Aloysia citriodora Palau Grown in Morocco. Adv. Pharmacol. Sci. 2017, 7801924. [Google Scholar] [CrossRef] [PubMed]
  32. Chaouki, W.; Leger, D.Y.; Liagre, B.; Beneytout, J.L.; Hmamouchi, M. Citral inhibits cell proliferation and induces apoptosis and cell cycle arrest in MCF-7 cells. Fundam. Clin. Pharmacol. 2009, 23, 549–556. [Google Scholar] [CrossRef] [PubMed]
  33. Mitropoulou, G.; Fitsiou, E.; Stavropoulou, E.; Papavassilopoulou, E.; Vamvakias, M.; Pappa, A.; Oreopoulou, A.; Kourkoutas, Y. Composition, antimicrobial, antioxidant, and antiproliferative activity of Origanum dictamnus (dittany) essential oil. Microb. Ecol. Health Dis. 2015, 6, 26543. [Google Scholar]
  34. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999, 26, 1231–1237. [Google Scholar] [CrossRef]
  35. Panayiotidis, M.; Tsolas, Ο.; Galaris, D. Glucose oxidase-produced H2O2 induces Ca2+ Dependent DNA damage in human peripheral blood lymphocytes. Free Radic. Biol. Med. 1999, 26, 548–556. [Google Scholar] [CrossRef]
  36. Roehm, N.W.; Rodgers, G.H.; Hatfield, S.M.; Glasebrook, A.L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods 1991, 142, 257–265. [Google Scholar] [CrossRef]
Sample Availability: Samples of the Lippia citriodora essential oil is available from the authors.
Figure 1. Detection of DNA damage caused by Lippia citriodora oil and citral in Jurkat cells using comet assay. Jurkat cells (2 × 104) were incubated with Lippia citriodora oil (A) or citral (B) for 20 min at room temperature. Results are shown as Mean ± S.D. * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 1. Detection of DNA damage caused by Lippia citriodora oil and citral in Jurkat cells using comet assay. Jurkat cells (2 × 104) were incubated with Lippia citriodora oil (A) or citral (B) for 20 min at room temperature. Results are shown as Mean ± S.D. * p < 0.05, ** p < 0.01, *** p < 0.001.
Molecules 23 00123 g001
Figure 2. Detection of the protective effect of Lippia citriodora oil and citral on H2O2-treated Jurkat cells. Jurkat cells (2 × 104) were preincubated with Lippia citriodora oil (A) or citral (B) for 20 min before treatment with H2O2 (6.66 μg/mL) for 20 min at room temperature. Results are shown as mean ± S.D. # p = 0.013 H2O2 vs. H2O2 and 640 μg/mL essential oil, # p < 0.05 relative to H2O2, *** p < 0.001 relative to control.
Figure 2. Detection of the protective effect of Lippia citriodora oil and citral on H2O2-treated Jurkat cells. Jurkat cells (2 × 104) were preincubated with Lippia citriodora oil (A) or citral (B) for 20 min before treatment with H2O2 (6.66 μg/mL) for 20 min at room temperature. Results are shown as mean ± S.D. # p = 0.013 H2O2 vs. H2O2 and 640 μg/mL essential oil, # p < 0.05 relative to H2O2, *** p < 0.001 relative to control.
Molecules 23 00123 g002
Figure 3. Antiproliferative activity of Lippia citriodora oil against a panel of five human cancer cell lines. Cancer cells were incubated with increasing concentrations of citral for 72 h. Estimation of cell viability was determined by the SRB assay. Representative figures of at least three experiments.
Figure 3. Antiproliferative activity of Lippia citriodora oil against a panel of five human cancer cell lines. Cancer cells were incubated with increasing concentrations of citral for 72 h. Estimation of cell viability was determined by the SRB assay. Representative figures of at least three experiments.
Molecules 23 00123 g003
Figure 4. Antiproliferative activity of citral against a panel of three human cancer cell lines. Cancer cells were incubated with increasing concentrations of citral for 72 h. Estimation of cell viability was determined by the SRB assay. Representative figures of at least three experiments.
Figure 4. Antiproliferative activity of citral against a panel of three human cancer cell lines. Cancer cells were incubated with increasing concentrations of citral for 72 h. Estimation of cell viability was determined by the SRB assay. Representative figures of at least three experiments.
Molecules 23 00123 g004
Table 1. Volatiles identified in the essential oil of Lippia citriodora and their relative percent (%) area.
Table 1. Volatiles identified in the essential oil of Lippia citriodora and their relative percent (%) area.
KRI*Compounds% Area
795trans-hex-2-enal0.024
805cis-hex-3-enol0.084
819trans-hex-2-enol0.013
920α-pinene0.041
946oct-1-en-3-one0.072
9546-methyl-hept-5-en-2-noe2.278
956oct-1-en-3-ol1.434
971octan-3-ol0.079
972myrcene0.100
978cis-hex-3-enyl acetate0.071
10081,8-cineol3.150
1010limonene2.166
1019cis-b-ocimenetrace
1030trans-b-ocimene0.386
1043sabinenehydrate0.267
1077nonanal0.053
1080linalol0.396
1137cis-isocitral0.485
1165a-terpineol1.119
1212nerol8.047
1215cis-citral17.160
1219piperitone0.193
1241geraniol5.720
1246trans-citral26.404
1278thymol or carvacrol0.462
1324eugenol0.190
1340geranic acid0.195
1360geranyl acetate0.999
1366a-copaene0.263
1367methyl eugenol0.129
1373b-bourbonene0.199
1400a-cedrene0.283
1405caryophyllene1.439
1462d-germacrene1.150
1464ar-curcumene2.098
1479zingiberene0.536
1479bicyclogermacrene1.750
1504cubenol A0.215
1543nerolidol0.753
1551spathulenol3.279
1554caryophyllene oxide1.375
1607iso-spathulenol0.452
1611T-cadinol0.558
KRI*: Kovats Retention Indices.
Table 2. Antimicrobial activity of the Lippia citriodora essential oil against common food spoilage and pathogenic microbes monitored by the disk diffusion assay.
Table 2. Antimicrobial activity of the Lippia citriodora essential oil against common food spoilage and pathogenic microbes monitored by the disk diffusion assay.
Lippia citriodora Essential OilCitral
Initial Inoculum
Microbial Species5 log cfu/mL7 log cfu/mL5 log cfu/mL7 log cfu/mL
Salmonella Enteritidis0010 ± 0.57 ± 0.3
Salmonella typhimurium0010 ± 0.38 ± 0.5
Escherichia coli0011 ± 0.77 ± 0.5
Listeria monocytogenes12 ± 0.710 ± 0.320 ± 0.315 ± 0.5
Staphylococcus epidermidis20 ± 0.2516 ± 0.325 ± 0.519 ± 0.3
Staphylococcus aureus13 ± 0.511 ± 0.723 ± 0.519 ± 0.3
Pseudomonas fragi0010 ± 0.57 ± 0.3
Saccharomyces cerevisiae20 ± 0.512 ± 0.725 ± 0.718 ± 0.3
The inhibition zones were measured in mm.
Table 3. MIC and NIC (μg/mL) of Lippia citriodora essential oil and citral against common food spoilage and pathogenic bacteria. Ciproxin was used as control.
Table 3. MIC and NIC (μg/mL) of Lippia citriodora essential oil and citral against common food spoilage and pathogenic bacteria. Ciproxin was used as control.
Lippia Citriodora Essential OilCitral *Ciproxin (Data Reproduced by Fitsiou et al. [12])
Microbial speciesMICNICMICNICMICNIC
Salmonella Enteritidis--7051 ± 266393 ± 180.976 ± 0.0010.957 ± 0.001
Salmonella typhimurium--7603 ± 266121 ± 90.979 ± 0.0010.964 ± 0.001
Escherichia coli--7024 ± 96340 ± 180.984 ± 0.0010.956 ± 0.002
Listeria monocytogenes1794 ± 9179 ± 96919 ± 184981 ± 180.979 ± 0.0010.968 ± 0.001
Staphylococcus epidermidis1758 ± 11538 ± 196954 ± 185779 ± 90.979 ± 0.0020.957 ± 0.002
Staphylococcus aureus923 ± 1998 ± 96901 ± 184972 ± 90.982 ± 0.0020.963 ± 0.003
Pseudomonas fragi--7112 ± 275235 ± 90.955 ± 0.0010.940 ± 0.002
* Mixture of 40% cis- and 60% trans-citral.
Table 4. Antioxidant activity of the essential oil of Lippia citriodora and citral using the DPPH and ABTS assays.
Table 4. Antioxidant activity of the essential oil of Lippia citriodora and citral using the DPPH and ABTS assays.
DPPHABTS
IC50 (mg/mL)IC50 (mg/mL)(μmolesEΑ/g) *
Lippia citriodora oil6.3 ± 0.253.08 ± 0.33115.2
Citraln.d.n.d.773.7
Ascorbic acid0.0054 ± 0.000350.0054 ± 0.00041-
Data are presented as Mean ± SD of at least three independent experiments, * micromoles ascorbic acid equivalent per gram of essential oil. Ascorbic acid was used as a positive control. n.d. = not determined.
Table 5. EC50 values of the essential oil of Lippia citriodora and its major component, citral, against different human cell lines. Etoposide was used as a positive control.
Table 5. EC50 values of the essential oil of Lippia citriodora and its major component, citral, against different human cell lines. Etoposide was used as a positive control.
EC50 (μg/mL)
HepG2Caco2MCF-7THP-1A375
Lippia citriodora oil74 ± 2.871 ± 2.689 ± 1.4111 ± 3.69.1 ± 0.6
Citral7 ± 0.353.7 ± 0.211.3 ± 0.19--
Etoposide0.60 ± 0.067.3 ± 0.631.67 ± 0.410.45 ± 0.013-
Data are presented as mean ± SD of at least three independent experiments.

Share and Cite

MDPI and ACS Style

Fitsiou, E.; Mitropoulou, G.; Spyridopoulou, K.; Vamvakias, M.; Bardouki, H.; Galanis, A.; Chlichlia, K.; Kourkoutas, Y.; Panayiotidis, M.Ι.; Pappa, A. Chemical Composition and Evaluation of the Biological Properties of the Essential Oil of the Dietary Phytochemical Lippia citriodora. Molecules 2018, 23, 123. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules23010123

AMA Style

Fitsiou E, Mitropoulou G, Spyridopoulou K, Vamvakias M, Bardouki H, Galanis A, Chlichlia K, Kourkoutas Y, Panayiotidis MΙ, Pappa A. Chemical Composition and Evaluation of the Biological Properties of the Essential Oil of the Dietary Phytochemical Lippia citriodora. Molecules. 2018; 23(1):123. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules23010123

Chicago/Turabian Style

Fitsiou, Eleni, Gregoria Mitropoulou, Katerina Spyridopoulou, Manolis Vamvakias, Haido Bardouki, Alex Galanis, Katerina Chlichlia, Yiannis Kourkoutas, Mihalis Ι. Panayiotidis, and Aglaia Pappa. 2018. "Chemical Composition and Evaluation of the Biological Properties of the Essential Oil of the Dietary Phytochemical Lippia citriodora" Molecules 23, no. 1: 123. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules23010123

Article Metrics

Back to TopTop